Akacid-medical-formulation, a novel biocidal oligoguanidine with antitumor activity reduces S-phase in prostate cancer cell lines through the Erk 1/2 mitogen-activated protein kinase pathway

Hannes Neuwirt, Hansgeorg Muller, Ilaria T R Cavarretta, Martin Tiefenthaler, Georg Bartsch, Guenther Konwalinka, Zoran Culig

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Akacid-medical-formulation, a novel biocidal oligoguanidine with antitumor activity reduces S-phase in prostate cancer cell lines through the Erk 1/2 mitogen-activated protein kinase pathway'. Together they form a unique fingerprint.

Medicine & Life Sciences